Table 3.
Antibiotics resistance report
| Cluster | No. of patients | No. of samples tested | AK | GEN | TOB | CIP | GAT | OF | MO | C | CAZ | CTR | IPM | MRP | PI | CL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 (Dec 2006) | 4 | 4 | 2 (50) | 3 (75) | 4 (100) | 0 | 1 (25) | 1 (25) | NT | 4 (100) | 3 (75) | NT | NT | NT | NT | NT |
| 2 (Sep 2011) | 2 | 2 | 2 (100) | NT | 0 | NT | 2 (100) | NT | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 0 | NT | NT | 2 (100) |
| 3 (Oct 2011) | 4 | 3 | 3 (100) | NT | 2 (66.6) | 3 (100) | 3 (100) | NT | NT | 3 (100) | 3 (100) | 3 (100) | 2 (66.6) | NT | NT | 0 |
| 4 (Mar 2012) | 9 | 9 | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 9 (100) | 0 | NT | NT | 0 |
| 5 (Dec 2012) | 13 | 11 | 0 | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 1 (9.09) | 11 (100) | 11 (100) | 0 | NT | 5 (45.4) | 0 |
| 6 (Mar 2018) | 30 | 11 | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 11 (100) | 0 | 4 (36.3) | 11 (100) | 9 (81.8) | 2 (18.1) | 1 (9.09) |
| Overall Resistance | 27 (67.5) | 34 (97.1) | 37 (92.5) | 34 (89.4) | 37 (92.5) | 32 (91.4) | 33 (100) | 30 (75) | 28 (70) | 29 (80.5) | 13 (36.1) | 9 (81.8) | 7 (31.8) | 3 (8.3) |
AK=Amikacin, GEN=Gentamicin, TOB=Tobramycin, CIP=Ciprofloxacin, GAT=Gatifloxacin, OF=Ofloxacin, MO=Moxifloxacin, C=Chloramphenicol, CAZ=Ceftazidime, CTR=Ceftriaxone, IPM=Imipenem, MRP=Meropenem, PI=Piperacillin, COL=Colistin, NT=Not tested. Numbers in bracket indicates percentage